John R. Sedor, MD, FASN, Secretary-Treasurer
John R. Sedor, MD is a graduate of the University of Virginia and the University of Virginia School of Medicine, and completed his residency training and nephrology fellowship at Case Western Reserve University and University Hospitals of Cleveland. He is a Professor of Medicine and a Professor of Physiology and Biophysics at Case Western Reserve University School of Medicine, Director of the NIDDK George O’Brien Renal Research Center, Associate Chair for Research in the Department of Medicine, Vice President of Research at MetroHealth System Campus, Director of the Case Center for the Study of Kidney Biology and Disease and Associate Chief Medical Officer for Research, MetroHealth. Dr. Sedor is board certified in internal medicine and nephrology.
Dr. Sedor is an active physician scientist whose research focuses on progressive kidney disease mechanisms. The overall goal of the lab is to define the clinical, cellular and genetic bases of kidney disease in order to identify new therapies and diagnostic tests. Current projects include identification of human nephropathy susceptibility genes and defining mechanisms of kidney disease progression using in vitro (cell culture) and animal models. Dr. Sedor’s clinical interests include consultative nephrology, especially patients with glomerular diseases and progressive chronic kidney disease. He has received numerous honors and awards including the National Kidney Foundation David M. Hume Award and has several times received recognition as one of the Best Doctors in America.
Dr. Sedor has served in many leadership roles at the American Society of Nephrology, including Chair of the Research Advocacy Committee, as a member of the Public Policy Board Chair, as Chair of the Program Committee (2007) and Chair of the Ad Hoc Research Policy Committee, 2009-2010, as Associate Editor of NephSAP, Co-Chair of the Organizing Committee, ASN/NIDDK Diabetic Nephropathy Research Retreat, 2004; Member American Society of Nephrology/National Kidney Foundation Joint Task Force on Research, 2002-2004; Chair, Clinical Sciences Committee, (2001-2004); Government Relations Committee 2001-2003.
Medicine is undergoing a structural change similar to the changes that have impacted the US automobile industry. Practice, teaching and research will need to adapt and thrive in an environment of constrained resources. Advances in clinical, basic and translational biomedical research have made this the most exciting time to practice medicine in my career. ASN has become a leading subspecialty society that actively and prospectively addresses challenges in the practice of medicine and the education of trainees and actively advocates for research in order to improve human health. I am gratified to be part of these efforts.